Who can use Pegasys(Peginterferon alfa-2a)?

Pegasys is indicated for adults with chronic hepatitis B or C virus (HCV) infections. For chronic hepatitis B, it is used in patients with compensated liver disease and evidence of viral replication. 

Who can use Pegasys(Peginterferon alfa-2a)?

In chronic HCV, it is prescribed for genotype 1, 2, 3, or 4 infections, often in combination with ribavirin. Contraindications include uncontrolled autoimmune diseases, severe depression, or decompensated liver disease (e.g., cirrhosis with complications). Patients must have adequate hematological and renal function. Prior to use, healthcare providers assess suitability based on medical history, viral load, liver status, and potential drug interactions. Pregnant individuals and those with hypersensitivity to interferon or peginterferon should avoid Pegasys. Always consult a physician for personalized treatment decisions.